Pfizer CEO Albert Bourla says mRNA technology was ‘counterintuitive’ being that Pfizer had less than 2 years of experience with it and no products on the market using it.
Pfizer CEO Albert Bourla says mRNA technology was ‘counterintuitive’ being that Pfizer had less than 2 years of experience with it and no products on the market using it.
Albert Bourla CEO of Pfizer, on why mRNA vaccine was counterintuitive. "I was surprised when they suggested to me that..